The frequency of IFNL3 T allele was also higher in patients with hepatic diseases compared to the lymphoproliferative diseases (MAF 0.44 vs. 0.36; OR = 1.77, 95%CI 1.40–2.25, p < 0.0001). This evidence concerns the gene IFNL3 and liver disorder.